In-Office Suprachoroidal Viscopexy for Acute Rhegmatogenous Retinal Detachment.

ABSTRACT:

Importance

In-office suprachoroidal viscopexy (SCVEXY) is a relatively new procedure for rhegmatogenous retinal detachment (RRD), but minimal information is available regarding outcomes and safety.

Objective

To report outcomes with in-office SCVEXY for primary acute RRD.

Design, setting, and participants

This retrospective case series was conducted at St Michael's Hospital in Toronto, Ontario, Canada from June 2023 to February 2024 among consecutive patients with primary acute RRDs who presented with retinal tears that were reachable with the current in-office SCVEXY technique in the temporal or nasal retina.

Exposure

Suprachoroidal injection of 0.6 mL of sodium hyaluronate, 2.3%, at the break location using a 30-gauge needle with a custom-made guard leaving 1

SUBMITTER: Muni RH 

PROVIDER: S-EPMC11739999 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature